Subscribe to MDT Magazine News

TeleHealth Services and Reading Hospital and Medical Center Partner to Reach Technology-Driven Patient Education Goals

September 14, 2010 3:32 am | by Bio-Medicine.Org | Comments

READING, Pa. and RALEIGH, N.C., Sept. 14 /- TeleHealth Services, the nation's leading provider of healthcare grade televisions and interactive patient education solutions, today announced a new partnership with The Reading Hospital and Medical Center (TRHMC). The 671-bed hospital chose...


Stereotaxis to Present at the CL King Best Ideas Conference and the Stifel Nicolaus Healthcare Conference

September 14, 2010 3:32 am | by Bio-Medicine.Org | Comments

ST. LOUIS, Sept. 14 /- Stereotaxis, Inc. (Nasdaq: STXS ) today announced that executive management will present at the following investor conferences: The CL King 8th Annual Best Ideas Conference to be held September 15-16, 2010 at the Omni Berkshire Place Hotel in New York City....


ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firm's Growing Client Base in Germany

September 14, 2010 12:33 am | by Bio-Medicine.Org | Comments

FRANKFURT, Germany, Sept. 14 /- Dr. Rolf Badenhoop M.D., a 20-year veteran of the consulting and pharmaceutical industries in Europe, recently joined global sales and marketing consulting firm ZS Associates as associate principal. Badenhoop is based in the company's Frankfurt office. "I...


SunEdison signs MOU for 400MW of solar projects with provincial government in Korea

September 13, 2010 10:34 pm | by I-Micronews | Comments

SunEdison, the solar energy development subsidiary of MEMC Electronic Materials (WFR ), and Gyeongsangnam-do ("GSND"), a provincial government in southeastern Korea, today announced the execution of a non-binding Memorandum of Understanding (MOU) for the establishment of 400 megawatts...

New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patients

September 13, 2010 10:31 pm | by EurekAlert | Comments

(Burness Communications) A widely prescribed class of drugs is highly effective in reducing common bone fractures in people with osteoporosis, but an expert panel announces that these same drugs -- when used long term -- may be related to unusual but serious fractures of the thigh bone.


Study identifies underlying dysfunction of seemingly non-critical heart condition

September 13, 2010 10:31 pm | by EurekAlert | Comments

(Nationwide Children's Hospital) Repairing small, seemingly benign holes in a child's heart may be more clinically important than previously thought, as dysfunction could be lurking out of sight. These are the findings from a study conducted by doctors and researchers at Nationwide...


Welsh scientists 'clone' human virus

September 13, 2010 4:37 pm | by EurekAlert | Comments

(Cardiff University) A team of Welsh scientists have successfully cloned a human virus offering new hope for the treatment of potentially life-threatening diseases. Human cytomegalovirus is a major infectious cause of congenital malformations worldwide. The virus is also known to...


Lung transplant now viable option at any age

September 13, 2010 4:36 pm | by Baylor College of Medicine | Comments

Due to scientific advancements, lung transplants are a reasonable option for those dealing with end-stage lung disease at any age, according to an expert at Baylor College of Medicine . "End-stage lung disease occurs when someone loses more than 70 percent of lung function as determined...


Faculty member's book profiles successful health care leaders

September 13, 2010 4:36 pm | by Arizona State University | Comments

ASU's Jack Gilbert has co-written a book, which challenges the view that new tools, processes and knowledge are enough to deliver the highest levels of safety, quality performance, employee engagement and financial more


ThermoGenesis Regains Compliance With NASDAQ Listing Rules

September 13, 2010 4:36 pm | by Bio-Medicine.Org | Comments

RANCHO CORDOVA, Calif., Sept. 13 /- ThermoGenesis Corp. (Nasdaq: KOOLD ), a leading supplier of innovative products and services that process and store adult stem cells, said today that it has been informed by NASDAQ that the Company is in compliance with all NASDAQ listing standards,...


Max Neeman International Expands Upon Cardiology and Device Trial Experience to Meet Increased Medical Device Development in India

September 13, 2010 4:35 pm | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C., Sept. 13 /- Max Neeman International, a leading Indian CRO, announces the expansion of therapeutic focused device clinical trial services in India. Max Neeman has formed an experienced and world class team of medical device experts specializing in carrying...


Can Your Child's Teacher Teach?

September 13, 2010 1:32 pm | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., September 13, 2010 — Education is an expensive investment. Historically, it has been a pre-packaged template of courses offered without warranty protection, or a money- back guarantee. The SME Education Foundation and its industry partner, Project Lead The Way...

USGI medical tissue anchors show durability beyond 1 year

September 13, 2010 12:33 pm | by EurekAlert | Comments

(USGI) USGI Medical Tissue Anchors show durability for over a year, overcoming a major barrier to incisionless, natural orifice surgeries.


Breakthrough in drug trial offers hope for heart attack patients

September 13, 2010 12:31 pm | by EurekAlert | Comments

(University of Sheffield) New findings from a major drug trial have brought experts a step closer to developing a drug which could prevent thousands of British deaths from heart attacks.


Genzyme's slimdown adding strength?

September 13, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | Comments

MHT life sciences report Julie Donnelly blogs: It strikes me that Genzyme might be trimming down before a marriage – either to French drug maker Sanofi-Aventis, who has proffered a rock worth $18.6 billion, or to some white knight who could ride in at the last moment, like in chick flicks.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.